Food and Drug Law Weekly

Centocor, Inc. - Enrollment in AbESTT-II phase III trial temporarily suspended due to safety concerns

Charite-University Medical School Berlin - Weight reduction causes changes in adiponectin oligomer composition

Children's Hospital of Michigan - Researchers' data advance breast cancer research

Children's National Medical Center, Washington - RMP-7 and carboplatin administration with radiotherapy deemed feasible

Chinese University of Hong Kong - Chinese herbal medicine intake assessed among preoperative patients in Hong Kong

Chonnam National University - Biweekly paclitaxel and cisplatin is effective in esophageal cancer patients

Cleveland Clinic Foundation - Atorvastatin safe and effective for patients with poor response to simvastatin

Cleveland Clinic Foundation - Induction and mode of action of viral stress-inducible murine proteins determined

Cleveland Clinic Foundation - Intensive statin treatment reduced progress of atherosclerosis compared with moderate regimen

Clinic L Mangiagalli, Milan - Second trimester amniocentesis does not increase vertical HIV transmission risk

Columbia University - Medical management most cost-effective for routine pediatric ADHD treatment

Cornell University, Ithaca - Fetal exposure to toxins could be behind rise in asthma, allergies, and autoimmune disorders

Dermatrends, Inc. - Drug-delivery company reports on its capability to deliver proton-pump inhibitors transdermally

Devers Eye Institute, Portland - Deep lamellar endothelial keratoplasty safe and effective

Dr. Ricardo Jorge National Institute of Health, Lisbon - Oxaliplatin has surprisingly potent mutagenic effects under some conditions

Duke University Medical Center, Durham - Immune therapy could treat leukemias, autoimmune diseases, transplant rejection

Erasmus Medical Center, Rotterdam - Proper treatment selection improves survival in early stage lung cancer patients

Forbes Medi-Tech, Inc. - U.S. phase II trial for cholesterol-lowering drug, FM-VP4, cleared

Geriatrics - Course offered on ethics in long-term care

HealthGrades - Healthgrades study: New hospital ratings show wide "quality chasm"

Howard Hughes Hughes Institute - New bioethics resources released

Inspire Pharmaceuticals, Inc. - Pharmaceutical company to request end of phase II meeting with U.S. FDA for CF drug

Institute of Environ. Science & Research, Porirua - Studies describe new findings in polio vaccines research

MediGene AG - New drug application filed with U.S. Food and Drug Administration for Polyphenon E Ointment

Medtronic, Inc. - Premarket approval application submitted to U.S. Food and Drug Administration for rhBMP-2

National Institute Infectious Disease, Tokyo - Vaccine, previously left unused in WHO eradication program, provides efficient protection

Pall Corp. - New system increases platelet availability and patient safety

Pfizer Inc - U.S. FDA approves Aromasin for adjuvant treatment of early breast cancer in postmenopausal women

Research Australia - Recruitment for ovarian cancer vaccine clinical trial complete

Sonus Pharmaceuticals, Inc. - Phase 3 trial of paclitaxel compound for treating metastatic breast cancer initiated

Telik, Inc. - U.S. FDA grants clearance to conduct clinical studies for myelodysplastic syndrome

U.S. Food & Drug Administration - Agency issues public health advisory on Strattera (atomoxetine) for attention deficit disorder

University of Illinois - Recent findings illuminate research in human papillomavirus

University of Texas Southwest Medical Center, Dallas - RiVax safe against ricin

University of Texas, Austin - Adherence to clozapine therapy improved by weekly clinician visits

VIVUS Inc. - Completing phase 3 study plan of testosterone for HSDD is result of U.S. FDA meeting

ViaCell Inc - Stem cell products company announces clinical hold on enrollment in CB001 study

Whitehead Institute for Biomedical Research - Researchers offer proof-of-concept for altered nuclear transfer